Needle Free Injection Market Research Report –Global Forecast to 2023

1. Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2023 Market Highlights: The global needle free injection market size is expected to touch USD 25,057.4 million by 2023 owing to high prevalence of diabetes and chronic diseases. Market Research Future’s (MRFR) latest study reveals that the market is predicted a 15.28 % CAGR during the forecast period (2018–2023). Needle free injections are medical devices which deliver drugs directly via the skin instead of using hypodermic needles as a medium. High demand for needle free injectors in home healthcare in North America and Europe is expected to augur market growth. In addition, rising investments in biopharmaceuticals are expected to provide the market a much-needed impetus. Awareness among patients regarding benefits of needle free injections is anticipated to prevent reuse of needles and reduce the probability of contamination. Increasing use of these injections by patients owing to its accurate dosage, pain relief, and low risks can lead to high market demand in the coming years. But high costs of these medical devices can pose a challenge to market growth. Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/6180 Global Market for Needle Free Injection – Segmental Analysis MRFR’s report offers a detailed segmental analysis of the market based on product, technology, usability, type of medication, site of delivery, application, and end-user. By product type, the market has been segmented into fillable and prefilled needle free injectors. The fillable segment is expected to be the biggest product till 2023, with the syringe being beneficial to the practitioner, with the vaccine filled according to the disease. Technologies covered in the report include laser- powered, jet-based, and spring-based. Among these, the jet-based segment can touch a size of USD 10,391.3 million by 2023 owing to a faster method of delivery as compared to other technologies. By usability, the market is segmented into reusable and disposable. The reusable segment is expected to register a 15.90% CAGR over the forecast period. By type of medication, the market is segmented into projectile/depot-based, powder-based, and liquid-based. The liquid-based segment held a large share of the market in 2017. It can continue to dominate till 2023 owing to its easy working mechanism. By site of medication, the market is segmented into intradermal, intramuscular, and subcutaneous injectors. The intramuscular segment is touted to generate maximum revenue for the needle free injection market owing to muscles absorbing vaccines at a much higher rate as compared to veins. Applications include oncology, vaccination, and insulin delivery. The insulin delivery segment is projected to expand at a 14.9% CAGR over the forecast period fueled by large pool of diabetics demanding a pain-free solution for receiving insulin. Major market end-users include hospitals and clinics, ambulatory surgical centers, and homecare settings. The hospitals and clinics Market Research Future

2. segment is projected to generate maximum revenue for the market by 2023 owing to high demand for sophisticated devices to deliver vaccines for chronic diseases. Regional Outlook The needle free injection market, on the basis of region, is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The Americas are expected to dominate the global market owing to prevalence of chronic diseases and demand for self- administrative devices. Technological breakthroughs in pharmaceutical and biotechnology sectors, investments by industry participants, and high awareness among patients are factors anticipated to fuel market growth over the forecast period. Europe is expected to register a significant growth rate over the forecast period due to the presence of well-established healthcare infrastructure and huge patient pool. The APAC needle free injection market is projected to showcase a robust CAGR over the forecast period owing to strong economies of India and China. Increased healthcare expenditures of these developing economies coupled with a large patient pool can spur market demand. Enhanced safety and quality standards adhered by manufacturers of these medical devices can culminate in remarkable product sales. The MEA market commands a smaller market share compared to others owing to stringent government policies and less emphasis on healthcare expenditure. Analysis Period Base Year - 2017 • Projection Period - From 2018 to 2023 • Market Denomination - USD Million • Conversion Rate - Considered as per the respective financial years Intended Audience • Government Research Institutes • Research and Development (R&D) Companies • Medical Devices Companies • Academic Institutes and Universities For the scope of research, the report offers a comprehensive analysis of the global needle free injection market. • Access Report Details @ https://www.marketresearchfuture.com/reports/needle-free-injection- market-6180 The report for Global market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear Market Research Future

3. picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions. Global Market for Needle Free Injection – Competitive Dashboard Some of the key players profiled in the market report PenJet Corporation, European Pharma Group, Endo Pharmaceuticals Inc., PharmaJet, Inc., National Medical Products Inc., INJEX Pharma GmBH, Valeritas Holdings, Inc., CROSSJECT, Antares Pharma Inc., MIKA MEDICAL CO., Inovio Pharmaceuticals Inc., Medical International Technology, Inc., and D'Antonio Consultants International, Inc. Investments in research and development and launch of new products are strategies employed by these players to acquire a larger market share. TOC: 1. Report Prologue 2. Market Introduction 2.1 Definition 2.2 Scope of the Study 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations 3. Research Methodology 3.1 Introduction 3.2 Primary Research 3.3 Secondary research 3.4 Market Size Estimation TOC…Continued Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/6180 About Market Research Future: Market Research Future

4. At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future